Stefania Vernazza

Dr. Stefania Vernazza

Department of Experimental Medicine, University of Genoa, Genoa, Italy
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SVStefania Vernazza
Stefania Vernazza
STSara Tirendi
Sara Tirendi
ABAnna Maria Bassi
Anna Maria Bassi
CTCarlo Enrico Traverso
Carlo Enrico Traverso
SSSergio Saccà
Sergio Saccà
Primary open-angle glaucoma (POAG) is the second leading cause of irreversible blindness worldwide. Increasing evidence suggests oxidative damage and immune response defects are key factors contributing to glaucoma onset. Indeed, both the failure of the trabecular meshwork tissue in the conventional outflow pathway and the neuroinflammation process, which drives the neurodegeneration, seem to be linked to the age-related over-production of free radicals (i.e., mitochondrial dysfunction) and to oxidative stress-linked immunostimulatory signaling. Several previous studies have described a wide range of oxidative stress-related makers which are found in glaucomatous patients, including low levels of antioxidant defences, dysfunction/activation of glial cells, the activation of the NF-κB pathway and the up-regulation of pro-inflammatory cytokines, and so on. However, the intraocular pressure is still currently the only risk factor modifiable by medication or glaucoma surgery. This present review aims to summarize the multiple cellular processes, which promote different risk factors in glaucoma including aging, oxidative stress, trabecular meshwork defects, glial activation response, neurodegenerative insults, and the altered regulation of immune response.

Verified
Journal Article
Open access
PDF file
SVStefania Vernazza
Stefania Vernazza
Francesco OddoneFrancesco Oddone
Francesco Oddone
STSara Tirendi
Sara Tirendi
ABAnna Maria Bassi
Anna Maria Bassi
Retinal ganglion cells (RGCs) are a population of neurons of the central nervous system (CNS) extending with their soma to the inner retina and with their axons to the optic nerve. Glaucoma represents a group of neurodegenerative diseases where the slow progressive death of RGCs results in a permanent loss of vision. To date, although Intra Ocular Pressure (IOP) is considered the main therapeutic target, the precise mechanisms by which RGCs die in glaucoma have not yet been clarified. In fact, Primary Open Angle Glaucoma (POAG), which is the most common glaucoma form, also occurs without elevated IOP. This present review provides a summary of some pathological conditions, i.e., axonal transport blockade, glutamate excitotoxicity and changes in pro-inflammatory cytokines along the RGC projection, all involved in the glaucoma cascade. Moreover, neuro-protective therapeutic approaches, which aim to improve RGC degeneration, have also been taken into consideration.

6 September 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SVStefania Vernazza
Stefania Vernazza
STSara Tirendi
Sara Tirendi
SSSonia Scarfì
Sonia Scarfì
MPMario Passalacqua
Mario Passalacqua
Francesco OddoneFrancesco Oddone
Francesco Oddone
SSSergio Saccà
Sergio Saccà
A physiologically relevant in vitro human-based model could be the ‘gold standard’ to clarify the pathological steps involved in glaucoma onset. In this regard, human 3D cultures may represent an excellent starting point to achieve this goal. Indeed, the 3D matrix allows to re-create the in vivo-like tissue architecture, maintaining its functionality and cellular behaviour, compared to the 2D model. Thus, we propose a comparison between the 2D and 3D in vitro models of human trabecular meshwork cells in terms of cellular responses after chronic stress exposure. Our results showed that 3D-cells are more sensitive to intracellular reactive oxidative specie production induced by hydrogen peroxide treatment, compared to 2D cultures. Additionally, in 3D cultures a more accurate regulation of the apoptosis trigger and cell adaptation mechanisms was detected than in 2D models. In line with these findings, the 3D-HTMC model shows the ability to better mimic the in vivo cell behaviour in adaptive responses to chronic oxidative stress than 2D.

19 July 2023 in Frontiers in Oncology
Verified
Journal Article
Open access
STSara Tirendi
Sara Tirendi
BMBarbara Marengo
Barbara Marengo
CDCinzia Domenicotti
Cinzia Domenicotti
ABAnna M. Bassi
Anna M. Bassi
VAVanessa Almonti
Vanessa Almonti
SVStefania Vernazza
Stefania Vernazza
Introduction: The latest GLOBOCAN 2021 reports that colorectal cancer (CRC) is the second leading cause of cancer-related death worldwide. Most CRC cases are sporadic and associated with several risk factors, including lifestyle habits, gut dysbiosis, chronic inflammation, and oxidative stress.Aim: To summarize the biology of CRC and discuss current therapeutic interventions designed to counteract CRC development and to overcome chemoresistance.Methods: Literature searches were conducted using PubMed and focusing the attention on the keywords such as “Current treatment of CRC” or “chemoresistance and CRC” or “oxidative stress and CRC” or “novel drug delivery approaches in cancer” or “immunotherapy in CRC” or “gut microbiota in CRC” or “systematic review and meta-analysis of randomized controlled trials” or “CSCs and CRC”. The citations included in the search ranged from September 1988 to December 2022. An additional search was carried out using the clinical trial database.Results: Rounds of adjuvant therapies, including radiotherapy, chemotherapy, and immunotherapy are commonly planned to reduce cancer recurrence after surgery (stage II and stage III CRC patients) and to improve overall survival (stage IV). 5-fluorouracil-based chemotherapy in combination with other cytotoxic drugs, is the mainstay to treat CRC. However, the onset of the inherent or acquired resistance and the presence of chemoresistant cancer stem cells drastically reduce the efficacy. On the other hand, the genetic-molecular heterogeneity of CRC often precludes also the efficacy of new therapeutic approaches such as immunotherapies. Therefore, the CRC complexity made of natural or acquired multidrug resistance has made it necessary the search for new druggable targets and new delivery systems.Conclusion: Further knowledge of the underlying CRC mechanisms and a comprehensive overview of current therapeutic opportunities can provide the basis for identifying pharmacological and biological barriers that render therapies ineffective and for identifying new potential biomarkers and therapeutic targets for advanced and aggressive CRC.

1 July 2016 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
Eleonora RussoEleonora Russo
Eleonora Russo
NGN. Gaglianone
N. Gaglianone
SBS. Baldassari
S. Baldassari
BPB. Parodi
B. Parodi
ICI. Croce
I. Croce
GCG. Caviglioli
G. Caviglioli

Verified
Journal Article
Open access
PDF file
SMSerena Mirata
Serena Mirata
VAVanessa Almonti
Vanessa Almonti
DGDario Di Giuseppe
Dario Di Giuseppe
LFLaura Fornasini
Laura Fornasini
SRSimona Raneri
Simona Raneri
Sonia ScarfìSonia Scarfì
Sonia Scarfì
Alveolar macrophages are the first line of defence against detrimental inhaled stimuli. To date, no comparative data have been obtained on the inflammatory response induced by different carcinogenic mineral fibres in the three main macrophage phenotypes: M0 (non-activated), M1 (pro-inflammatory) and M2 (alternatively activated). To gain new insights into the different toxicity mechanisms of carcinogenic mineral fibres, the acute effects of fibrous erionite, crocidolite and chrysotile in the three phenotypes obtained by THP-1 monocyte differentiation were investigated. The three mineral fibres apparently act by different toxicity mechanisms. Crocidolite seems to exert its toxic effects mostly as a result of its biodurability, ROS and cytokine production and DNA damage. Chrysotile, due to its low biodurability, displays toxic effects related to the release of toxic metals and the production of ROS and cytokines. Other mechanisms are involved in explaining the toxicity of biodurable fibrous erionite, which induces lower ROS and toxic metal release but exhibits a cation-exchange capacity able to alter the intracellular homeostasis of important cations. Concerning the differences among the three macrophage phenotypes, similar behaviour in the production of pro-inflammatory mediators was observed. The M2 phenotype, although known as a cell type recruited to mitigate the inflammatory state, in the case of asbestos fibres and erionite, serves to support the process by supplying pro-inflammatory mediators.